243 related articles for article (PubMed ID: 19954345)
1. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.
Dovey M; White RM; Zon LI
Zebrafish; 2009 Dec; 6(4):397-404. PubMed ID: 19954345
[TBL] [Abstract][Full Text] [Related]
2. Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion.
McConnell AM; Mito JK; Ablain J; Dang M; Formichella L; Fisher DE; Zon LI
Dev Biol; 2019 May; 449(2):107-114. PubMed ID: 29883661
[TBL] [Abstract][Full Text] [Related]
3. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
Santoriello C; Gennaro E; Anelli V; Distel M; Kelly A; Köster RW; Hurlstone A; Mione M
PLoS One; 2010 Dec; 5(12):e15170. PubMed ID: 21170325
[TBL] [Abstract][Full Text] [Related]
4. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
5. The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.
Yen J; White RM; Wedge DC; Van Loo P; de Ridder J; Capper A; Richardson J; Jones D; Raine K; Watson IR; Wu CJ; Cheng J; Martincorena I; Nik-Zainal S; Mudie L; Moreau Y; Marshall J; Ramakrishna M; Tarpey P; Shlien A; Whitmore I; Gamble S; Latimer C; Langdon E; Kaufman C; Dovey M; Taylor A; Menzies A; McLaren S; O'Meara S; Butler A; Teague J; Lister J; Chin L; Campbell P; Adams DJ; Zon LI; Patton EE; Stemple DL; Futreal PA
Genome Biol; 2013; 14(10):R113. PubMed ID: 24148783
[TBL] [Abstract][Full Text] [Related]
6. Dissecting Oncogenic RAS Signaling in Melanoma Development in Genetically Engineered Zebrafish Models.
Badrock AP; Hurlstone A
Methods Mol Biol; 2021; 2262():411-422. PubMed ID: 33977492
[TBL] [Abstract][Full Text] [Related]
7. NRAS
Banik I; Cheng PF; Dooley CM; Travnickova J; Merteroglu M; Dummer R; Patton EE; Busch-Nentwich EM; Levesque MP
Pigment Cell Melanoma Res; 2021 Mar; 34(2):150-162. PubMed ID: 32910840
[TBL] [Abstract][Full Text] [Related]
8. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
Chagani S; Wang R; Carpenter EL; Löhr CV; Ganguli-Indra G; Indra AK
BMC Cancer; 2017 Nov; 17(1):736. PubMed ID: 29121869
[TBL] [Abstract][Full Text] [Related]
9. Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.
Coleman DJ; Chagani S; Hyter S; Sherman AM; Löhr CV; Liang X; Ganguli-Indra G; Indra AK
Mol Cancer Res; 2015 Jan; 13(1):186-96. PubMed ID: 25189354
[TBL] [Abstract][Full Text] [Related]
10. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro.
Eskandarpour M; Huang F; Reeves KA; Clark E; Hansson J
Int J Cancer; 2009 Jan; 124(1):16-26. PubMed ID: 18814281
[TBL] [Abstract][Full Text] [Related]
12. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
13. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.
Anelli V; Santoriello C; Distel M; Köster RW; Ciccarelli FD; Mione M
Zebrafish; 2009 Dec; 6(4):417-24. PubMed ID: 20047469
[TBL] [Abstract][Full Text] [Related]
14. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling.
Forloni M; Dogra SK; Dong Y; Conte D; Ou J; Zhu LJ; Deng A; Mahalingam M; Green MR; Wajapeyee N
Elife; 2014 Feb; 3():e01460. PubMed ID: 24550252
[TBL] [Abstract][Full Text] [Related]
15. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.
Patton EE; Widlund HR; Kutok JL; Kopani KR; Amatruda JF; Murphey RD; Berghmans S; Mayhall EA; Traver D; Fletcher CD; Aster JC; Granter SR; Look AT; Lee C; Fisher DE; Zon LI
Curr Biol; 2005 Feb; 15(3):249-54. PubMed ID: 15694309
[TBL] [Abstract][Full Text] [Related]
16. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
18. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.
Feng Y; Lau E; Scortegagna M; Ruller C; De SK; Barile E; Krajewski S; Aza-Blanc P; Williams R; Pinkerton AB; Jackson M; Chin L; Pellecchia M; Bosenberg M; Ronai ZA
Pigment Cell Melanoma Res; 2013 Jan; 26(1):136-42. PubMed ID: 23035722
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
Ki DH; He S; Rodig S; Look AT
Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]